Perfect scores across all seven transparency categories: authentic images, accurate advertising, proactive disclaimers about compounded medications, and easy cancellation
Cost and access: the indirect side effect While not a pharmacological side effect, the cost of these medications creates real-world consequences that affect adherence and outcomes
Dr Nomathemba Chandiwana, chief scientific officer at South Africas Desmond Tutu Health Foundation, and a specialist in obesity, who was not involved in the study, said: This could be very significant for South Africa and many African countries and low and middle-income countries [LMICs] at large where cost has been one of the main barriers to access. She said analysis suggested about 27% of adults worldwide met the criteria for drugs such as semaglutide and importantly, most of those live in LMICs where access to these medicines is extremely limited
Switching from OZEMPIC to RYBELSUS (formulation R2) One week after discontinuing 0.5 mg of subcutaneous OZEMPIC, start 4 mg or 9 mg of RYBELSUS (formulation R2) orally once daily
Careful Administration (Use with Caution) 13
